Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Epigenetics in breast cancer therapy—New strategies and future nanomedicine perspectives

  • Buocikova, Verona
  • Ríos-Mondragón, Iván
  • Pilalis, Eleftherios
  • Chatziioannou, Aristotelis
  • Miklikova, Svetlana
  • Mego, Michal
  • Pajuste, Karlis
  • Rucins, Martins
  • El Yamani, Naouale
  • Longhin, Eleonora Marta
  • Sobolev, Arkadij
  • Freixanet, Muriel
  • Puntes, Víctor F.
  • Plotniece, Aiva
  • Dusinska, María
  • Cimpan, Mihaela Roxana
  • Gabelova, Alena
  • Smolkova, Bozena
This article belongs to the Special Issue Epigenetic Therapy: The State of Play in Highly Aggressive Diseases., Epigenetic dysregulation has been recognized as a critical factor contributing to the development of resistance against standard chemotherapy and to breast cancer progression via epithelial-to-mesenchymal transition. Although the efficacy of the first-generation epigenetic drugs (epi-drugs) in solid tumor management has been disappointing, there is an increasing body of evidence showing that epigenome modulation, in synergy with other therapeutic approaches, could play an important role in cancer treatment, reversing acquired therapy resistance. However, the epigenetic therapy of solid malignancies is not straightforward. The emergence of nanotechnologies applied to medicine has brought new opportunities to advance the targeted delivery of epi-drugs while improving their stability and solubility, and minimizing off-target effects. Furthermore, the omics technologies, as powerful molecular epidemiology screening tools, enable new diagnostic and prognostic epigenetic biomarker identification, allowing for patient stratification and tailored management. In combination with new-generation epi-drugs, nanomedicine can help to overcome low therapeutic efficacy in treatment-resistant tumors. This review provides an overview of ongoing clinical trials focusing on combination therapies employing epi-drugs for breast cancer treatment and summarizes the latest nano-based targeted delivery approaches for epi-drugs. Moreover, it highlights the current limitations and obstacles associated with applying these experimental strategies in the clinics., This research was funded by ERA-NET EuroNanoMed II INNOCENT, by the Slovak Research and Development Agency (APVV), grant No. APVV-16-0010, APVV-16-0178, by the European Union’s Horizon 2020 research and innovation program under grant agreement No. 857381, project VISION (Strategies to strengthen scientific excellence and innovation capacity for early diagnosis of gastrointestinal cancers), by ERA-NET EuroNanoMed III CELLUX, H2020-NMBP-TO-IND-2019 SABYDOMA, contract No. 862296 and by Scientific Grant Agency (VEGA), contracts No. 2/0271/17, 2/0138/20 and 2/0052/18., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Heterogeneous Rate Constant for Amorphous Silica Nanoparticle Adsorption on Phospholipid Monolayers

  • Vakurov, Alex
  • Drummond-Brydson, Rik
  • William, Nicola
  • Sanver, Didem
  • Bastús, Neus G.
  • Moriones, Oscar Hernando
  • Puntes, Víctor F.
  • Nelson, Andrew
The interaction of amorphous silica nanoparticles with phospholipid monolayers and bilayers has received a great deal of interest in recent years and is of importance for assessing potential cellular toxicity of such species, whether natural or synthesized for the purpose of nanomedical drug delivery and other applications. This present communication studies the rate of silica nanoparticle adsorption on to phospholipid monolayers in order to extract a heterogeneous rate constant from the data. This rate constant relates to the initial rate of growth of an adsorbed layer of nanoparticles as SiO2 on a unit area of the monolayer surface from unit concentration in dispersion. Experiments were carried out using the system of dioleoyl phosphatidylcholine (DOPC) monolayers deposited on Pt/Hg electrodes in a flow cell. Additional studies were carried out on the interaction of soluble silica with these layers. Results show that the rate constant is effectively constant with respect to silica nanoparticle size. This is interpreted as indicating that the interaction of hydrated SiO2 molecular species with phospholipid polar groups is the molecular initiating event (MIE) defined as the initial interaction of the silica particle surface with the phospholipid layer surface promoting the adsorption of silica nanoparticles on DOPC. The conclusion is consistent with the observed significant interaction of soluble SiO2 with the DOPC layer and the established properties of the silica–water interface., We acknowledge EU for supporting ENNSATOX GA No. 229244, HISENTS GA No. 685817, and SABYDOMA GA No 862296., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A template wizard for the cocreation of machine-readable data-reporting to harmonize the evaluation of (nano)materials

  • Jeliazkova, Nina
  • Longhin, Eleonora
  • El Yamani, Naouale
  • Rundén-Pran, Elise
  • Moschini, Elisa
  • Serchi, Tommaso
  • Vrček, Ivana Vinković
  • Burgum, Michael J.
  • Doak, Shareen H.
  • Cimpan, Mihaela Roxana
  • Rios-Mondragon, Ivan
  • Cimpan, Emil
  • Battistelli, Chiara
  • Bossa, Cecilia
  • Tsekovska, Rositsa
  • Drobne, Damjana
  • Novak, Sara
  • Repar, Neža
  • Ammar, Ammar
  • Nymark, Penny
  • Di Battista, Veronica
  • Sosnowska, Anita
  • Puzyn, Tomasz
  • Kochev, Nikolay
  • Iliev, Luchesar
  • Jeliazkov, Vedrin
  • Reilly, Katie
  • Lynch, Iseult
  • Bakker, Martine
  • Delpivo, Camila
  • Sánchez-Jiménez, A.
  • Fonseca, Ana Sofia
  • Manier, Nicolas
  • Fernández-Cruz, M. L.
  • Rashid, Shahzad
  • Willighagen, Egon L.
  • Apostolova, Margarita D.
  • Dusinska, Maria
43 Pág., Making research data findable, accessible, interoperable and reusable (FAIR) is typically hampered by a lack of skills in technical aspects of data management by data generators and a lack of resources. We developed a Template Wizard for researchers to easily create templates suitable for consistently capturing data and metadata from their experiments. The templates are easy to use and enable the compilation of machine-readable metadata to accompany data generation and align them to existing community standards and databases, such as eNanoMapper, streamlining the adoption of the FAIR principles. These templates are citable objects and are available as online tools. The Template Wizard is designed to be user friendly and facilitates using and reusing existing templates for new projects or project extensions. The wizard is accompanied by an online template validator, which allows self-evaluation of the template (to ensure mapping to the data schema and machine readability of the captured data) and transformation by an open-source parser into machine-readable formats, compliant with the FAIR principles. The templates are based on extensive collective experience in nanosafety data collection and include over 60 harmonized data entry templates for physicochemical characterization and hazard assessment (cell viability, genotoxicity, environmental organism dose-response tests, omics), as well as exposure and release studies. The templates are generalizable across fields and have already been extended and adapted for microplastics and advanced materials research. The harmonized templates improve the reliability of interlaboratory comparisons, data reuse and meta-analyses and can facilitate the safety evaluation and regulation process for (nano) materials., Supported by H2020 projects RiskGONE (no. 814425), HARMLESS (no. 953183), Gov4Nano (no. 814401), SABYDOMA (862296), SBD4NANO (862195), PLASTICFATE (no. 965367), POLYRISK (964766), NANOREG2 (no. 646221), PROPLANET (no. 101091842), NanoSolveIT (no. 814572), CompSafeNano (no. 101008099), TWINALT (no. 952404), VISION (no. 857381), KAPPA project EYFORTX2 (no. T001000099-PZ-2021), TEPCAN project (NCBR no. NOR/POLNOR/TEPCAN/0057/ 2019-00), hCOMET project (COST Action, CA 15132), Slovenian Research Agency projects P1-0207 and P1-0184, and by the Norwegian Research Council project NanoBioReal (no. 288768)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Hazard assessment of nanomaterials: how to meet the requirements for (next generation) risk assessment

  • Longhin, Eleonora Marta
  • Ríos-Mondragón, Iván
  • Mariussen, Espen
  • Zheng, Congying
  • Busquets-Fité, Martí
  • Gajewska, Agnieszka
  • Hofshagen, Ole-Bendik
  • Bastús, Neus G.
  • Puntes, Víctor F.
  • Cimpan, Mihaela Roxana
  • Shaposhnikov, Sergey
  • Dusinska, María
  • Rundén-Pran, Elise
[Background] Hazard and risk assessment of nanomaterials (NMs) face challenges due to, among others, the numerous existing nanoforms, discordant data and conflicting results found in the literature, and specific challenges in the application of strategies such as grouping and read-across, emphasizing the need for New Approach Methodologies (NAMs) to support Next Generation Risk Assessment (NGRA). Here these challenges are addressed in a study that couples physico-chemical characterization with in vitro investigations and in silico similarity analyses for nine nanoforms, having different chemical composition, sizes, aggregation states and shapes. For cytotoxicity assessment, three methods (Alamar Blue, Colony Forming Efficiency, and Electric Cell-Substrate Impedance Sensing) are applied in a cross-validation approach to support NAMs implementation into NGRA., [Results] The results highlight the role of physico-chemical properties in eliciting biological responses. Uptake studies reveal distinct cellular morphological changes. The cytotoxicity assessment shows varying responses among NMs, consistent among the three methods used, while only one nanoform gave a positive response in the genotoxicity assessment performed by comet assay., [Conclusions] The study highlights the potential of in silico models to effectively identify biologically active nanoforms based on their physico-chemical properties, reinforcing previous knowledge on the relevance of certain properties, such as aspect ratio. The potential of implementing in vitro methods into NGRA is underlined, cross-validating three cytotoxicity assessment methods, and showcasing their strength in terms of sensitivity and suitability for the testing of NMs., This work was supported by the Norwegian Research Council project NanoBioReal (grant no. 288768), and by the H2020 projects TWINALT (grant no. 952404—H2020-WIDESPREAD-2020–5) and SABYDOMA (grant no. 862296). I.R.M. would like to thank the L. Meltzers Høyskolenfond 2022 for financial support and M.R.C. to UH-nett Vest, Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Hazard assessment of nanomaterials: how to meet the requirements for (next generation) risk assessment

  • Longhin, Eleonora
  • Rios Mondragon, Ivan
  • Mariussen, Espen
  • Zheng, congying
  • Busquets-Fité, Martí
  • Gajewicz, Agnieszka
  • Franco Puntes, Victor
Hazard assessment; Nanomaterials; New approach methodologies, Avaluació de perills; Nanomaterials; Noves metodologies d'enfocament, Evaluación de peligros; Nanomateriales; Nuevas metodologías de enfoque, Background: Hazard and risk assessment of nanomaterials (NMs) face challenges due to, among others, the numerous existing nanoforms, discordant data and conflicting results found in the literature, and specific challenges in the application of strategies such as grouping and read-across, emphasizing the need for New Approach Methodologies (NAMs) to support Next Generation Risk Assessment (NGRA). Here these challenges are addressed in a study that couples physico-chemical characterization with in vitro investigations and in silico similarity analyses for nine nanoforms, having different chemical composition, sizes, aggregation states and shapes. For cytotoxicity assessment, three methods (Alamar Blue, Colony Forming Efficiency, and Electric Cell-Substrate Impedance Sensing) are applied in a cross-validation approach to support NAMs implementation into NGRA. Results: The results highlight the role of physico-chemical properties in eliciting biological responses. Uptake studies reveal distinct cellular morphological changes. The cytotoxicity assessment shows varying responses among NMs, consistent among the three methods used, while only one nanoform gave a positive response in the genotoxicity assessment performed by comet assay. Conclusions: The study highlights the potential of in silico models to effectively identify biologically active nanoforms based on their physico-chemical properties, reinforcing previous knowledge on the relevance of certain properties, such as aspect ratio. The potential of implementing in vitro methods into NGRA is underlined, cross-validating three cytotoxicity assessment methods, and showcasing their strength in terms of sensitivity and suitability for the testing of NMs., This work was supported by the Norwegian Research Council project NanoBioReal (grant no. 288768), and by the H2020 projects TWINALT (grant no. 952404—H2020-WIDESPREAD-2020–5) and SABYDOMA (grant no. 862296). I.R.M. would like to thank the L. Meltzers Høyskolenfond 2022 for financial support and M.R.C. to UH-nett Vest.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Heterogeneous rate constant for amorphous silica nanoparticle adsorption on phospholipid monolayers

  • Vakurov, Alex|||0000-0001-6654-4287
  • Drummond-Brydson, Rik
  • William, Nicola
  • Sanver, Didem|||0000-0001-6696-9541
  • Bastús, Neus G.|||0000-0002-3144-7986
  • Moriones, Oscar Hernando|||0000-0003-0310-0210
  • Puntes, Víctor|||0000-0001-8996-9499
  • Nelson, Andrew L.|||0000-0002-5842-7459
The interaction of amorphous silica nanoparticles with phospholipid monolayers and bilayers has received a great deal of interest in recent years and is of importance for assessing potential cellular toxicity of such species, whether natural or synthesized for the purpose of nanomedical drug delivery and other applications. This present communication studies the rate of silica nanoparticle adsorption on to phospholipid monolayers in order to extract a heterogeneous rate constant from the data. This rate constant relates to the initial rate of growth of an adsorbed layer of nanoparticles as SiO on a unit area of the monolayer surface from unit concentration in dispersion. Experiments were carried out using the system of dioleoyl phosphatidylcholine (DOPC) monolayers deposited on Pt/Hg electrodes in a flow cell. Additional studies were carried out on the interaction of soluble silica with these layers. Results show that the rate constant is effectively constant with respect to silica nanoparticle size. This is interpreted as indicating that the interaction of hydrated SiO molecular species with phospholipid polar groups is the molecular initiating event (MIE) defined as the initial interaction of the silica particle surface with the phospholipid layer surface promoting the adsorption of silica nanoparticles on DOPC. The conclusion is consistent with the observed significant interaction of soluble SiO with the DOPC layer and the established properties of the silica-water interface.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Hazard assessment of nanomaterials: how to meet the requirements for (next generation) risk assessment

  • Longhin, Eleonora
  • Rios Mondragon, Ivan
  • Mariussen, Espen
  • Zheng, congying
  • Busquets-Fité, Martí
  • Gajewicz, Agnieszka
  • Franco Puntes, Victor
Hazard assessment; Nanomaterials; New approach methodologies, Avaluació de perills; Nanomaterials; Noves metodologies d'enfocament, Evaluación de peligros; Nanomateriales; Nuevas metodologías de enfoque, Background: Hazard and risk assessment of nanomaterials (NMs) face challenges due to, among others, the numerous existing nanoforms, discordant data and conflicting results found in the literature, and specific challenges in the application of strategies such as grouping and read-across, emphasizing the need for New Approach Methodologies (NAMs) to support Next Generation Risk Assessment (NGRA). Here these challenges are addressed in a study that couples physico-chemical characterization with in vitro investigations and in silico similarity analyses for nine nanoforms, having different chemical composition, sizes, aggregation states and shapes. For cytotoxicity assessment, three methods (Alamar Blue, Colony Forming Efficiency, and Electric Cell-Substrate Impedance Sensing) are applied in a cross-validation approach to support NAMs implementation into NGRA. Results: The results highlight the role of physico-chemical properties in eliciting biological responses. Uptake studies reveal distinct cellular morphological changes. The cytotoxicity assessment shows varying responses among NMs, consistent among the three methods used, while only one nanoform gave a positive response in the genotoxicity assessment performed by comet assay. Conclusions: The study highlights the potential of in silico models to effectively identify biologically active nanoforms based on their physico-chemical properties, reinforcing previous knowledge on the relevance of certain properties, such as aspect ratio. The potential of implementing in vitro methods into NGRA is underlined, cross-validating three cytotoxicity assessment methods, and showcasing their strength in terms of sensitivity and suitability for the testing of NMs., This work was supported by the Norwegian Research Council project NanoBioReal (grant no. 288768), and by the H2020 projects TWINALT (grant no. 952404—H2020-WIDESPREAD-2020–5) and SABYDOMA (grant no. 862296). I.R.M. would like to thank the L. Meltzers Høyskolenfond 2022 for financial support and M.R.C. to UH-nett Vest.